MedChemComm p. 653 - 664 (2015)
Update date:2022-08-02
Topics:
He, Xiaomeng
Jiang, Yan
Zhang, Yongqiang
Wu, Shanchao
Dong, Guoqiang
Liu, Na
Liu, Yang
Yao, Jianzhong
Miao, Zhenyuan
Wang, Yan
Zhang, Wannian
Sheng, Chunquan
Due to increasing incidence and mortality of invasive fungal infections, discovery and development of new generations of antifungal agents represents a challenging task. On the basis of our previously reported triazole-benzyloxypiperidinyl lead compound, a series of novel triazole antifungal agents containing piperidine-oxadiazole side chains were rationally designed and synthesized. Most of the target compounds showed excellent inhibitory activity against clinically important fungal pathogens. In particular, compounds 6g (MIC = 0.031 μg mL-1) and 11b (MIC = 0.016 μg mL-1) were highly active against Candida albicans including fluconazole-resistant strains. Moreover, they showed inhibitory activity against hyphal formation with low toxicity, which were promising leads for further development. This journal is
View MoreContact:18710867521(wechat)
Address:Rm10516,Galaxy Tech Building #2,No.25 Tangyan Rd,Hi-Tech Zone,Xi'an, China
Shijiazhuang Yunxuan Im&Export Co.,Ltd.
Contact:+86-311-83037514
Address:No.6 Hongbin Road
Hangzhou Hysen Pharma co.,Ltd.
website:http://www.hysenpharma.cn/
Contact:0086-571-88298791
Address:#701,Gudun Road Hangzhou
Taizhou Sunny Chemical Co.,Ltd
Contact:+86-523-86920899 +86-13951172783
Address:No.11 Xingyuang road, Gaoyong Chemical Industry Park, Gaogang Jiangsu China
Feiyang Biotechnology Co., Ltd.
Contact:+86-533-7866339
Address:Qilu Chemistry Park, 200m north of Management Community Building of Park
Doi:10.1016/j.molstruc.2009.04.006
(2009)Doi:10.1134/S0036023608060120
(2008)Doi:10.1021/jo00388a003
(1987)Doi:10.1039/c1cc14292e
(2011)Doi:10.1002/hlca.200490159
(2004)Doi:10.1016/j.tet.2008.01.118
(2008)